脱发药龙头蔓迪国际递表港交所;和铂医药深化与阿斯利康的合作 | 医药早参

每日经济新闻
Nov 25

丨2025年11月25日星期二丨  NO.1 和铂医药宣布与阿斯利康深化推进全球战略合作  11月24日,和铂医药发布公告,称将更新与深化推进其与阿斯利康于今年3月建立的全球战略合作。在本次合作中,双方将基于各自专业技术知识,共同发现和开发包括抗体偶联药物(ADC)和T细胞衔接器(TCE)在内的新一代生物疗法。根据协议,阿斯利康将在未来四年内,每年持续向和铂医药提名研发项目,并获得这些项目的授权...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10